Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Immunogenicity and safety of a novel quadrivalent meningococcal conjugate vaccine (MenACWY-CRM) in healthy Korean adolescents and adults.

Lee HJ, Chung MH, Kim WJ, Hong YJ, Choi KM, Lee J, Oh CE, Welsch JA, Kim KH, Hong KB, Dagnew AF, Bock H, Dull PM, Odrljin T.

Int J Infect Dis. 2014 Nov;28:204-10. doi: 10.1016/j.ijid.2014.06.008. Epub 2014 Oct 12.

PMID:
25316331
[PubMed - in process]
Free Article
2.

Safety and Immunogenicity of Typhoid Fever and Yellow Fever Vaccines When Administered Concomitantly With Quadrivalent Meningococcal ACWY Glycoconjugate Vaccine in Healthy Adults.

Alberer M, Burchard G, Jelinek T, Reisinger E, Beran J, Hlavata LC, Forleo-Neto E, Dagnew AF, Arora AK.

J Travel Med. 2014 Oct 13. doi: 10.1111/jtm.12164. [Epub ahead of print]

PMID:
25308927
[PubMed - as supplied by publisher]
3.

Co-administration of a meningococcal glycoconjugate ACWY vaccine with travel vaccines: a randomized, open-label, multi-center study.

Alberer M, Burchard G, Jelinek T, Reisinger E, Beran J, Meyer S, Forleo-Neto E, Gniel D, Dagnew AF, Arora AK.

Travel Med Infect Dis. 2014 Sep-Oct;12(5):485-93. doi: 10.1016/j.tmaid.2014.04.011. Epub 2014 May 9.

PMID:
24873986
[PubMed - in process]
4.

Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth.

Dagnew AF, Hussein J, Abebe M, Zewdie M, Mihret A, Bedru A, Chanyalew M, Yamuah L, Medhin G, Bang P, Doherty TM, Hailu A, Aseffa A.

BMC Res Notes. 2012 Aug 7;5:415. doi: 10.1186/1756-0500-5-415.

PMID:
22870897
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Variation in reported neonatal group B streptococcal disease incidence in developing countries.

Dagnew AF, Cunnington MC, Dube Q, Edwards MS, French N, Heyderman RS, Madhi SA, Slobod K, Clemens SA.

Clin Infect Dis. 2012 Jul;55(1):91-102. doi: 10.1093/cid/cis395. Epub 2012 Apr 20. Review.

PMID:
22523262
[PubMed - indexed for MEDLINE]
Free Article
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk